Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:450-457

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, L.
Right arrow Articles by Brooks, V. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, L.
Right arrow Articles by Brooks, V. L.

(Hypertension. 1997;29:450.)
© 1997 American Heart Association, Inc.


State-of-the-Art-Lecture

Sodium Intake, Angiotensin II Receptor Blockade, and Baroreflex Function in Conscious Rats

Ling Xu; Virginia L. Brooks

From the Department of Physiology and Pharmacology, Oregon Health Sciences University, Portland.

Correspondence to Virginia L. Brooks, PhD, Department of Physiology and Pharmacology, L334, The Oregon Health Sciences University, Portland, OR 97201-3098. E-mail brooksv{at}ohsu.edu

The hypothesis that endogenous angiotensin II (Ang II) chronically supports baroreflex control of lumbar sympathetic nerve activity (LSNA) and heart rate (HR) via AT1 but not AT2 receptors was tested in conscious, normotensive rats. Rats were fed either a sodium deficient diet (LS) to increase circulating Ang II or a high-sodium diet (HS) for 2 to 3 weeks. One to two days after surgery to implant catheters and nerve electrodes, baroreflex curves were produced before and 40 minutes after intravenous administration of the AT1 antagonist losartan (10 mg/kg) or the AT2 antagonist PD123319 (500 µg/kg+50 µg/kg-1/min-1). Mean arterial pressure (MAP) after losartan was maintained at basal levels with methoxamine. Forty minutes after losartan in LS rats, LSNA (46±5 to 22±1% max) and HR (414±7 to 387±8 bpm) were decreased (P<.05). Losartan decreased reflex control of LSNA more in LS than in HS rats (P<.05), as indicated by reductions in maximum LSNA (98±2 to 78±3% max) and minimum LSNA (42±5 to 21±5% max). Losartan also shifted reflex control of LSNA to a lower pressure in both groups, but the effect was larger in LS rats (-21±3 [LS] versus -9±2 [HS] mm Hg at basal LSNA; P<.05). Maximum gain was unaltered in either group. Similarly, losartan reduced maximum HR (534±6 to 495±9 bpm) and shifted the HR curve leftward (114±5 to 105±4 mm Hg) in LS but not in HS rats. In general, no changes were observed in MAP or baroreflex control of LSNA and HR after PD123319 in LS rats. These results suggest that in conscious, normotensive LS rats, endogenous Ang II supports LSNA and HR over a wide MAP range via AT1 but not AT2 receptors.


Key Words: losartan • PD123319 • baroreflex • sodium-deprived rats • lumbar sympathetic nerve activity • heart rate • AT1 • AT2

Abbreviations: % max = percent of maximum • %con = percent of control • Ang = angiotensin • AT = angiotensin type • BBB = blood-brain barrier • HR = heart rate • HS = high sodium • LS = low sodium • LSNA = lumbar sympathetic nerve activity • MAP = mean arterial pressure • MAP100 = mean arterial pressure at 100% control lumbar sympathetic nerve activity • MAPmid = mean arterial pressure at midrange of the baroreflex curve • MET = methoxamine • NP = nitroprusside • PE = phenylephrine




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. S. P. Tan, S. Killinger, J. Horiuchi, and R. A. L. Dampney
Baroreceptor reflex modulation by circulating angiotensin II is mediated by AT1 receptors in the nucleus tractus solitarius
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2267 - R2278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
V. L. Brooks, Y. Qi, and T. L. O'Donaughy
Increased osmolality of conscious water-deprived rats supports arterial pressure and sympathetic activity via a brain action
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1248 - R1255.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Dendorfer, A. Thornagel, W. Raasch, O. Grisk, K. Tempel, and P. Dominiak
Angiotensin II Induces Catecholamine Release by Direct Ganglionic Excitation
Hypertension, September 1, 2002; 40(3): 348 - 354.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
V. Gross, R. Plehm, J. Tank, J. Jordan, A. Diedrich, M. Obst, and F. C. Luft
Heart Rate Variability and Baroreflex Function in AT2 Receptor-Disrupted Mice
Hypertension, August 1, 2002; 40(2): 207 - 213.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. F. DiBona
Nervous Kidney : Interaction Between Renal Sympathetic Nerves and the Renin-Angiotensin System in the Control of Renal Function
Hypertension, December 1, 2000; 36(6): 1083 - 1088.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. J. Scislo, R. A. Augustyniak, and D. S. O'Leary
Differential arterial baroreflex regulation of renal, lumbar, and adrenal sympathetic nerve activity in the rat
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R995 - R1002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Xu, J. P. Collister, J. W. Osborn, and V. L. Brooks
Endogenous ANG II supports lumbar sympathetic activity in conscious sodium-deprived rats: role of area postrema
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R46 - R55.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Sanchez-Palacios, S. Y. Jones, and G. F. Dibona
Role of angiotensin in renal sympathetic activation in nephrotic syndrome
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R808 - R813.
[Abstract] [Full Text] [PDF]